Solianis Monitoring AG (Zurich, Switzerland) has recently completed a study of its wearable, noninvasive, multisensor glucose monitor that tracks blood [MORE]
Genetic Engineering & Biotechnology News reported recently that GSK’s deal with Actelion, worth almost $3.2 billion, for Actelion’s insomnia drug [MORE]
BioWorld Today and Medical Devices Daily has a 200 page market analysis (cost $599) for biomaterials, covering such things as [MORE]